Skip to main content

Cero Therapeutics Holdings, Inc.

CERO
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001870404

No open-market purchases or sales by Cero Therapeutics Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Other share classesCEROW

Holders of 5% or more of CERO

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Cero Therapeutics Holdings, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of CERO
HolderLatest formStakeChangeFirst filedLatest filingFiling
Atwood Brian G13D/A9.90%511.8K shares+3.20 ppfrom 6.70%Feb 7, 20252 filingsApr 4, 2025SEC
Tibbs Isaiah13G8.67%1.83M sharesNewMar 12, 20261 filingMar 12, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

6 Schedule 13D and 13G filings on Cero Therapeutics Holdings, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on CERO
Filed (ET)FilerFormStakeChangeEvent dateFiling
Mar 12, 20263:38 PM ETTibbs Isaiah13G8.67%1.83M sharesNewFeb 19, 2026SEC
Aug 14, 20259:02 PM ETArmistice Capital, LLCand 1 other13G/A4.99%63.3K shares−5.00 ppfrom 9.99%Below 5%Jun 30, 2025SEC
May 15, 20253:12 PM ETArmistice Capital, LLCand 1 other13G9.99%584.5K sharesNewMar 31, 2025SEC
Apr 4, 20257:17 PM ETAtwood Brian Gand 2 others13D/A9.90%511.8K shares+3.20 ppfrom 6.70%Mar 31, 2025SEC
Feb 7, 20255:21 PM ETAtwood Brian Gand 2 others13D/A6.70%202.4K shares–Feb 7, 2025SEC
Dec 17, 20247:26 PM ETYK Bioventures Opportunities GP I, LLCand 3 others13G/A0.00%17.0K shares–Below 5%Dec 13, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Cero Therapeutics Holdings, Inc. shares.

No Form 144 notices for Cero Therapeutics Holdings, Inc. are on file.